Table 1: Total quarterly costs and cost per user of atypical antipsychotics at the start and end of the study period Atypical antipsychotic | First quarter 2007 | First quarter 2013 |
---|
Total cost, $ | % overall costs | Cost per user, $ | Total cost, $ | % overall costs | Cost per user, $ |
---|
Overall | 10 993 284 | - | 217.74 | 8 518 981 | - | 137.58 |
Risperidone | 2 201 115 | 20.0 | 95.26 | 2 061 866 | 24.2 | 110.41 |
Olanzapine | 5 815 987 | 52.9 | 428.59 | 1 890 328 | 22.2 | 152.75 |
Quetiapine | 2 976 182 | 27.1 | 181.08 | 3 365 143 | 39.5 | 104.59 |
Paliperidone | - | - | - | 394 855 | 4.6 | 953.76 |
Ziprasidone | - | - | - | 65 639 | 0.8 | 362.64 |
Aripiprazole | - | - | - | 741 151 | 8.7 | 349.60 |